KualaLumpur:MGRC

Malaysian Genomics Unveils Strategic Advances in Biopharmaceuticals

Retrieved on: 
Tuesday, August 29, 2023
Vaccine, Optimism, Genomics, MOH, Danna Azrieli, Ministry, Cosmeceutical, LBT, CGMP, PBT, Ministry of Health (Saudi Arabia), FMCG, Wound healing, Fine chemical, Health

PETALING JAYA, Malaysia, Aug 29, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, recorded a revenue of RM2.23 million for the 4th quarter ended 30 June 2023.

Key Points: 
  • PETALING JAYA, Malaysia, Aug 29, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, recorded a revenue of RM2.23 million for the 4th quarter ended 30 June 2023.
  • The Group will continue to implement stringent credit control policy as they move forward with their initiatives, particularly with Rejuvium.
  • For the current year-to-date, MGRC reported a revenue of RM8.36 million, a decrease from RM28.36 million in the previous year.
  • Malaysian Genomics Resource Centre Bhd: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/
    Copyright 2023 ACN Newswire .

Malaysian Genomics Inks Agreement in Expansion to Bangladesh

Retrieved on: 
Monday, May 15, 2023
Defamation, ASC, Obesity, IAC, Arthritis, Genomics, Pathology, Spine, Jim O'Neill, Baron O'Neill of Gatley, SCA, CAR, BRICS, Jonathan Wells (intelligent design advocate), Tetraplegia, Tendinopathy, Rare-earth element, Drug

PETALING JAYA, Malaysia, May 15, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced a strategic cooperation agreement (SCA) with Toticell Limited for the distribution of the Group's products in Bangladesh.

Key Points: 
  • PETALING JAYA, Malaysia, May 15, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced a strategic cooperation agreement (SCA) with Toticell Limited for the distribution of the Group's products in Bangladesh.
  • Mr. Sasha Nordin, CEO of Malaysian Genomics said, "Bangladesh represents a market with vast opportunities given its population of approximately 165 million people.
  • Malaysian Genomics is delighted to cooperate with Toticell to bring our products and services to Bangladesh."
  • Mr. Azri Azerai, Executive Director of Malaysian Genomics, said, "This collaboration with Toticell falls in line with Malaysian Genomics' strategic expansion plan which includes diversifying geographically and globally."

Malaysian Genomics to Boost Play on the Football Pitch

Retrieved on: 
Monday, February 27, 2023
DNA, Genomics, Go KL City Bus, Athlete, Dato, Genetic testing, Rare-earth element, Management, Dietary supplement

Dr. Nurul Aqma Anis, Malaysian Genomics' Head of Special Projects and Quality said, "Having started offering genetic screening tests in 2012, Malaysian Genomics is Southeast Asia's most well-established DNA company and our genetic test for peak athletic performance is one of the latest in our test portfolio.

Key Points: 
  • Dr. Nurul Aqma Anis, Malaysian Genomics' Head of Special Projects and Quality said, "Having started offering genetic screening tests in 2012, Malaysian Genomics is Southeast Asia's most well-established DNA company and our genetic test for peak athletic performance is one of the latest in our test portfolio.
  • "I was amazed by the tremendous amount of information generated in my genetic screening report from Malaysian Genomics.
  • I can't wait to experience the positive impact it has on me on the pitch," said KLCFC defender, Giancarlo Gallifuoco.
  • Malaysian Genomics Resource Centre Bhd: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/
    Copyright 2023 ACN Newswire .

Malaysian Genomics Pivots to Biopharmaceuticals for Growth

Retrieved on: 
Friday, February 24, 2023
Marketing, Immunotherapy, LBT, Genomics, Research, FMCG, Growth, PBT, Vaccine, Fine chemical

PETALING JAYA, Malaysia, Feb 24, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group recorded a revenue of RM1.64 million for the second quarter ended 31 December 2022 (2Q 2023).

Key Points: 
  • PETALING JAYA, Malaysia, Feb 24, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group recorded a revenue of RM1.64 million for the second quarter ended 31 December 2022 (2Q 2023).
  • This amount is down from RM7.63 million in 2Q 2022, as the Group moved its focus from vaccines to biopharmaceuticals.
  • Azri Azerai, Executive Director of Malaysian Genomics, said, "Our Group remains committed to sustaining growth over the longer term by focusing on immunotherapy and cell therapies under the biopharmaceutical business we are expanding through our distribution network in the Middle East and Southeast Asia.
  • Malaysian Genomics Resource Centre Bhd: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/
    Copyright 2023 ACN Newswire .

Malaysian Genomics to Collaborate on Cannabinoid R&D

Retrieved on: 
Friday, February 24, 2023
Biotechnology, Knowledge, Genomics, MAHSA University, Hospital, Bandar Saujana Putra, Research, R, Growth, Dato, Student, Fine chemical, Nursing

Kensana Health Canada is a biotechnology specialist focused on the R&D of cannabinoid treatments and management of wounds partnered with a German multinational phytopharmaceutical company.

Key Points: 
  • Kensana Health Canada is a biotechnology specialist focused on the R&D of cannabinoid treatments and management of wounds partnered with a German multinational phytopharmaceutical company.
  • MAHSA University is a private Malaysian university focused on allied health sciences with a 48-acre campus in Bandar Saujana Putra, Selangor and a diverse population of students from 75 countries.
  • Mr. Ken Clement, Chairman and CEO of Kensana Health Canada said, "We look forward to working with Malaysian Genomics and MAHSA by providing our technology and knowledge in advancing the R&D efforts.
  • Malaysian Genomics Resource Centre Bhd: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/
    Copyright 2023 ACN Newswire .

Malaysian Genomics to Offer World's First DNA-Driven Fertility Test

Retrieved on: 
Wednesday, February 22, 2023
Fertility, Reproductive medicine, Genomics, Patient, Gene, Antibiotics

Under the strategic collaboration, Divine Genes' genetic test for reproductive health will be added to Malaysian Genomics' genetic test portfolio, which will market and distribute these tests in Malaysia and overseas.

Key Points: 
  • Under the strategic collaboration, Divine Genes' genetic test for reproductive health will be added to Malaysian Genomics' genetic test portfolio, which will market and distribute these tests in Malaysia and overseas.
  • Sasha Nordin, Chief Executive Officer of Malaysian Genomics said, "Decreasing fertility and birth rates are common across the world, and demand for reproductive medicine is growing in many countries.
  • This new, pioneering DNA-driven fertility test can help reproductive health specialists and their patients make important decisions in support of improving the outcome of fertility treatments.
  • This test will form a critical part of Malaysian Genomics' genetic screening portfolio of over 550 tests available across Southeast Asia and the Middle East where we have a presence."

Malaysian Genomics Explores R&D Collaboration with SIRIM

Retrieved on: 
Monday, January 9, 2023
SIRIM, R, Dato, Precision medicine, Genomics, Research, Biofuel, Food security, Fine chemical, Rare-earth element

SIRIM Berhad is wholly owned by the Malaysian Government, and is focused on R&D, standardisation and quality.

Key Points: 
  • SIRIM Berhad is wholly owned by the Malaysian Government, and is focused on R&D, standardisation and quality.
  • Encik Sasha Nordin, Chief Executive Officer of Malaysian Genomics, said, "SIRIM and Malaysian Genomics have complementary experiences, resources, and technology assets.
  • President and Group Chief Executive Officer of SIRIM Berhad, Dato' Indera Dr Ahmad Sabirin Arshad said, "We look forward to working closely with Malaysian Genomics on R&D projects that can benefit the country and domestic industries.
  • Malaysian Genomics Resource Centre Berhad: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/
    Copyright 2023 ACN Newswire .